Aspire Biopharma Holdings, Inc. Warrant (ASBPW)

• 1 day: -34.96%
• 5 days: -33.67%
• 1 month: -55.46%
• 3 months: -42.86%
• 6 months: 88.68%
• Year to date: -15.79%
• 1 year: 24.22%
• 5 years: -88.57%
• 10 years: -88.57%
• Sector: Healthcare
• Industry: Biotechnology

About: Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

1% more capital invested

Capital invested by funds: $625K [Q4 2024] → $630K (+$5.21K) [Q1 2025]

0% more funds holding

Funds holding: 26 [Q4 2024] → 26 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2